Project-specific health-based exposure limit and occupational toxicology assessment support. The agreed scope may include PDE/ADE derivation, OEL derivation and OEB/OHC banding, based on the exact substance form, available evidence and intended product or workplace context.
CAS Registry Number
58-85-5
Molecular formula
C10H16N2O3S
Molecular weight
244.31 g/mol
Drug class
Water-soluble vitamin B7coenzyme for carboxylase enzymes
Mechanism of action
Functions as a covalently bound cofactor for acetyl-CoA carboxylase, pyruvate carboxylase, propionyl-CoA carboxylase and 3-methylcrotonyl-CoA carboxylase, supporting fatty-acid synthesis, gluconeogenesis and amino-acid catabolism.
Indications / reported uses
Prevention and treatment of biotin deficiency, including deficiency due to inherited biotinidase or holocarboxylase synthetase disorders under specialist care
Routine supplementation when dietary intake or absorption is inadequate; evidence does not support treating hair loss or brittle nails in the absence of deficiency
Scope is agreed for the exact substance form, intended use, exposure route, workplace context and available toxicological evidence.
PDE/ADE: critical effects, point of departure and justified adjustment factors.
OEL: inhalation hazards, exposure duration and workplace conditions.
OEB/OHC: evidence-based banding where requested; a band is not a numerical OEL.
Report: scientific rationale, source data, assumptions, uncertainties and limitations.
Assessment scope
PDE/ADE and OEL/OEB assessment
ReguSight provides project-specific support for Biotin PDE/ADE, OEL and OEB/OHC assessments. This combined profile covers the Biotin Permitted Daily Exposure (PDE) report (the Biotin PDE report); Acceptable Daily Exposure (ADE) is the corresponding health-based daily exposure terminology. It also covers the Biotin Occupational Exposure Limit (OEL) report (the Biotin OEL report). PDE/ADE derivation and workplace exposure assessment are distinct scientific outputs; a band is not a numerical OEL.
Assessment may cover
PDE/ADE derivation using relevant toxicological evidence, critical effects, a justified point of departure and adjustment factors.
The EMA HBEL guideline informs PDE/ADE assessments in relevant shared-facility contexts. ECHA and HSE sources address workplace exposure limits; NIOSH provides occupational exposure-banding guidance. The applicable framework depends on the assessment question and jurisdiction.